[go: up one dir, main page]

NO20005696L - BASB029-polynukleotid(er) og polypeptider fra Neisseria Meningitidis - Google Patents

BASB029-polynukleotid(er) og polypeptider fra Neisseria Meningitidis

Info

Publication number
NO20005696L
NO20005696L NO20005696A NO20005696A NO20005696L NO 20005696 L NO20005696 L NO 20005696L NO 20005696 A NO20005696 A NO 20005696A NO 20005696 A NO20005696 A NO 20005696A NO 20005696 L NO20005696 L NO 20005696L
Authority
NO
Norway
Prior art keywords
polypeptides
neisseria meningitidis
basb029
basb029 polynucleotide
polynucleotide
Prior art date
Application number
NO20005696A
Other languages
English (en)
Other versions
NO20005696D0 (no
NO326994B1 (no
Inventor
Jean-Louis Ruelle
Original Assignee
Smithkline Beecham Biolog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10831992&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20005696(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham Biolog filed Critical Smithkline Beecham Biolog
Publication of NO20005696D0 publication Critical patent/NO20005696D0/no
Publication of NO20005696L publication Critical patent/NO20005696L/no
Publication of NO326994B1 publication Critical patent/NO326994B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1217Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Neisseriaceae (F)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53DNA (RNA) vaccination
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Plant Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
NO20005696A 1998-05-13 2000-11-10 Polypeptid og fragmenter derav, polynukleotid, ekspresjonsvektor, vertscelle, fremgangsmate, vaksinesammensetning, anvendelse samt antistoff. NO326994B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9810276.7A GB9810276D0 (en) 1998-05-13 1998-05-13 Novel compounds
PCT/EP1999/003255 WO1999058683A2 (en) 1998-05-13 1999-05-07 BASB029 POLYNUCLEOTIDE(S) AND POLYPEPTIDES FROM $i(NEISSERIA MENINGITIDIS)

Publications (3)

Publication Number Publication Date
NO20005696D0 NO20005696D0 (no) 2000-11-10
NO20005696L true NO20005696L (no) 2001-01-11
NO326994B1 NO326994B1 (no) 2009-03-30

Family

ID=10831992

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20005696A NO326994B1 (no) 1998-05-13 2000-11-10 Polypeptid og fragmenter derav, polynukleotid, ekspresjonsvektor, vertscelle, fremgangsmate, vaksinesammensetning, anvendelse samt antistoff.
NO20090955A NO20090955L (no) 1998-05-13 2009-03-02 BASB029-polynukleotid(er) og -polypeptider fra Neisseria meningitidis

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20090955A NO20090955L (no) 1998-05-13 2009-03-02 BASB029-polynukleotid(er) og -polypeptider fra Neisseria meningitidis

Country Status (23)

Country Link
US (3) US6780419B1 (no)
EP (2) EP1078063B1 (no)
JP (2) JP4707832B2 (no)
KR (4) KR100673674B1 (no)
CN (1) CN1322127C (no)
AT (1) ATE311457T1 (no)
AU (1) AU750032B2 (no)
BR (1) BR9910396A (no)
CA (1) CA2328403C (no)
CY (1) CY1105676T1 (no)
CZ (1) CZ299612B6 (no)
DE (1) DE69928658T2 (no)
DK (1) DK1078063T3 (no)
ES (1) ES2252946T3 (no)
GB (1) GB9810276D0 (no)
HU (1) HUP0102479A3 (no)
IL (2) IL139613A0 (no)
NO (2) NO326994B1 (no)
NZ (1) NZ508323A (no)
PL (1) PL197449B1 (no)
TR (1) TR200003347T2 (no)
WO (1) WO1999058683A2 (no)
ZA (1) ZA200006523B (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9726398D0 (en) * 1997-12-12 1998-02-11 Isis Innovation Polypeptide and coding sequences
SG152917A1 (en) 1998-01-14 2009-06-29 Chiron Srl Neisseria meningitidis antigens
GB9810276D0 (en) * 1998-05-13 1998-07-15 Smithkline Beecham Biolog Novel compounds
AU2457100A (en) 1999-02-26 2000-09-14 Chiron S.P.A. Enhancement of bactericidal activity of neisseria antigens with oligonucleotidescontaining cg motifs
GB9916529D0 (en) * 1999-07-14 1999-09-15 Chiron Spa Antigenic peptides
EP2275552B1 (en) 1999-10-29 2015-09-09 GlaxoSmithKline Biologicals SA Neisserial antigenic peptides
GB9928196D0 (en) 1999-11-29 2000-01-26 Chiron Spa Combinations of B, C and other antigens
EP2275129A3 (en) * 2000-01-17 2013-11-06 Novartis Vaccines and Diagnostics S.r.l. Outer membrane vesicle (OMV) vaccine comprising N. meningitidis serogroup B outer membrane proteins
IL150822A0 (en) 2000-01-25 2003-02-12 Univ Queensland PROTEINS COMPRISING CONSERVED REGIONS OF NEISSERIA MENINGITIDIS SURFACE ANTIGEN NhhA
CN101139590B (zh) 2000-02-28 2012-07-18 启龙股份公司 奈瑟球菌蛋白质的杂交表达
MXPA04000653A (es) 2001-07-27 2004-11-22 Chiron Srl Adhesinas de meningococcus nada, app y orf 40.
DK2255826T3 (en) 2002-08-02 2016-06-20 Glaxosmithkline Biologicals Sa Neisserial vaccine compositions comprising a combination of antigens.
DE60335477D1 (de) 2002-10-11 2011-02-03 Novartis Vaccines & Diagnostic Polypeptidimpstoffe zum breiten schutz gegen hypervirulente meningokokken-linien
ATE506963T1 (de) 2003-10-02 2011-05-15 Novartis Vaccines & Diagnostic Kombinationsimpfstoffe gegen meningitis
US7459930B2 (en) * 2006-11-14 2008-12-02 Micron Technology, Inc. Digital calibration circuits, devices and systems including same, and methods of operation
GB0700562D0 (en) 2007-01-11 2007-02-21 Novartis Vaccines & Diagnostic Modified Saccharides
GB0916570D0 (en) 2009-09-21 2009-10-28 Royal Holloway & Bedford New C Method
ES2663872T3 (es) 2010-03-11 2018-04-17 Glaxosmithkline Biologicals S.A. Composición inmunogénica o vacuna contra infección o enfermedad bacteriana gramnegativa, por ejemplo, por Neisseria
SG11201403877PA (en) * 2012-01-05 2014-09-26 Deutsches Krebsforsch Means and methods for treating or diagnosing idh1 r132h mutant-positive cancers
WO2018022031A1 (en) 2016-07-27 2018-02-01 Prysmian S.P.A. Flexible optical-fiber ribbon

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4769240A (en) * 1980-09-15 1988-09-06 Bactex, Inc. Pili of neisseria and vaccine compositions containing same
US4702911A (en) * 1985-09-27 1987-10-27 Immunomed Corporation Preparation of bacterium pili subunits and vaccines containing pili subunits
RU2023448C1 (ru) 1987-07-30 1994-11-30 Сентро Насьональ Де Биопрепарадос Способ получения вакцины против различных патогенных серотипов менингита нейссера группы в
FR2682041B1 (fr) * 1991-10-03 1994-01-14 Pasteur Merieux Serums Vaccins Vaccin contre les infections a neisseria meningitidis.
US6245337B1 (en) * 1994-08-25 2001-06-12 Washington University Haemophilus adherence and penetration proteins
US6121037A (en) * 1994-10-18 2000-09-19 Stojiljkovic; Igor Bacterial hemoglobin receptor genes
US5646259A (en) * 1995-03-24 1997-07-08 St. Louis University DNA encoding haemophilus adhesion proteins
US6265567B1 (en) * 1995-04-07 2001-07-24 University Of North Carolina At Chapel Hill Isolated FrpB nucleic acid molecule
CU22559A1 (es) * 1996-01-17 1999-05-03 Ct Ingenieria Genetica Biotech Sistema de expresión de antígenos heterologos en e. coli como proteínas de fusión
GB9726398D0 (en) * 1997-12-12 1998-02-11 Isis Innovation Polypeptide and coding sequences
SG152917A1 (en) * 1998-01-14 2009-06-29 Chiron Srl Neisseria meningitidis antigens
GB9810276D0 (en) * 1998-05-13 1998-07-15 Smithkline Beecham Biolog Novel compounds
EP1228217B1 (en) * 1999-04-30 2012-11-21 Novartis Vaccines and Diagnostics S.r.l. Conserved neisserial antigens

Also Published As

Publication number Publication date
JP2002514424A (ja) 2002-05-21
KR20080070073A (ko) 2008-07-29
ZA200006523B (en) 2001-11-12
US20090093622A1 (en) 2009-04-09
NO20005696D0 (no) 2000-11-10
AU4142099A (en) 1999-11-29
ATE311457T1 (de) 2005-12-15
CY1105676T1 (el) 2010-12-22
KR100673674B1 (ko) 2007-01-23
HK1036300A1 (en) 2001-12-28
KR20010043571A (ko) 2001-05-25
CA2328403C (en) 2013-11-05
CZ299612B6 (cs) 2008-09-17
DE69928658T2 (de) 2006-06-14
IL139613A0 (en) 2002-02-10
HUP0102479A2 (hu) 2001-10-28
PL345281A1 (en) 2001-12-03
KR20060076789A (ko) 2006-07-04
DK1078063T3 (da) 2006-04-03
IL139613A (en) 2014-03-31
US6780419B1 (en) 2004-08-24
ES2252946T3 (es) 2006-05-16
DE69928658D1 (de) 2006-01-05
US20040265332A1 (en) 2004-12-30
JP4707832B2 (ja) 2011-06-22
EP1078063B1 (en) 2005-11-30
EP1078063A2 (en) 2001-02-28
AU750032B2 (en) 2002-07-11
HUP0102479A3 (en) 2004-10-28
WO1999058683A9 (en) 2002-05-02
CZ20004202A3 (en) 2001-05-16
KR100897951B1 (ko) 2009-05-18
JP2010166921A (ja) 2010-08-05
TR200003347T2 (tr) 2001-06-21
KR20100019461A (ko) 2010-02-18
GB9810276D0 (en) 1998-07-15
NZ508323A (en) 2002-10-25
CN1322127C (zh) 2007-06-20
NO326994B1 (no) 2009-03-30
EP1621623A2 (en) 2006-02-01
NO20090955L (no) 2001-01-11
WO1999058683A2 (en) 1999-11-18
PL197449B1 (pl) 2008-03-31
EP1621623A3 (en) 2009-02-18
CA2328403A1 (en) 1999-11-18
CN1309707A (zh) 2001-08-22
WO1999058683A3 (en) 2000-04-06
BR9910396A (pt) 2001-10-30

Similar Documents

Publication Publication Date Title
NO20005696D0 (no) BASB029-polynukleotid(er) og polypeptider fra Neisseria Meningitidis
WO1999055873A3 (en) Basb006 polynucleotide(s) and polypeptides from neisseria meningitis
NO20005952L (no) Antigene polypeptider fra Neisseria Meningitidis, tilsvarende polynukleotider og beskyttende antistoffer
DK1112366T3 (da) Polynucleotider og polypeptider BASB033 fra Neisseria Meningitidis samt deres anvendelser
CY1108280T1 (el) Basb205 πολυπεπτιδια και πολυνουκλεοτιδια που τα κωδικοποιουν
DK1163343T3 (da) Neisseria meningitidis antigene polypeptider, tilsvarende polynukleotider og beskyttende antistoffer
GB9809683D0 (en) Novel compounds
DK1078064T3 (da) Forbindelser fra moraxella catarrhalis
GB9812163D0 (en) Novel compounds
GB9812440D0 (en) Novel compounds
ATE527360T1 (de) Neue verbindungen abgeleitet von neisseria meningitidis
GB9918208D0 (en) Novel compounds
HK1042515A1 (zh) 來自腦膜炎球菌的basb055多核苷酸和多肽,其使用法
GB9918302D0 (en) Novel compounds
GB9918003D0 (en) Novel compounds
DK1196586T3 (da) BASB111-polypeptid og -polynukleotid fra moraxella catharralis
HK1042924A1 (zh) 從淋球性腦膜炎獲得的basb059多肽
GB9918206D0 (en) Novel compounds
GB9918281D0 (en) Novel compounds

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees